CNMD
$37.34
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures.
Recent News
DraftKings, Eli Lilly downgraded: Wall Street's top analyst calls
DraftKings, Eli Lilly downgraded: Wall Street's top analyst calls
A Look At CONMED (CNMD) Valuation After Recent Weak Share Price Momentum
CONMED (CNMD) has been on some investors’ radars after recent share performance, with the stock showing negative returns over the past month and past 3 months. This has prompted closer attention to its current valuation. See our latest analysis for CONMED. At a share price of $38.40, CONMED’s recent 7 day share price return of 10.68% decline and year to date share price return of 5.23% decline sit alongside a 1 year total shareholder return of 34.34% decline. Together, these moves point to...
3 Stocks Under $50 with Open Questions
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models.
Here's Why You Should Retain CONMED Stock in Your Portfolio Now
CNMD's growth rests on AirSeal, Buffalo Filter and BioBrace as supply chains normalize, even as tariffs and a GI exit pressure EPS.
PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the healthcare industry showing significant job losses.